US Patent 11400099 Drug-induced epigenetic remodeling to prevent fibrosis
Patent 11400099 was granted and assigned to Thomas Jefferson University on August, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11400099 Drug-induced epigenetic remodeling to prevent fibrosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.